LONG-TERM SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OF MODERATE OR HIGH ACTIVITY (RESULTS OF PHASE III MULTICENTER EXTENSION CLINICAL STUDY ML28124)

LONG-TERM SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OF MODERATE OR HIGH ACTIVITY (RESULTS OF PHASE III MULTICENTER EXTENSION CLINICAL STUDY ML28124)

Objective: to assess the long-term safety and efficiency of tocilizumab (TCZ) therapy in patients with early rheumatoid arthritis (RA) of moderate and high activity, who have completed the basic WA19926 study, as well as the rate of sustained drug-free remission.Subjects and methods. A long-term ope...

Full description

Bibliographic Details
Main Authors: E. L. Nasonov, M. L. Stanislav, V. I. Mazurov, T. M. Chernykh, V. N. Sorotskaya, T. S. Salnikova, R. S. Saikovsky, O. V. Reshet’ko, T. A. Popova, E. I. Shmidt, V. P. Tyurin, N. P. Shilkina, I. N. Bokarev, M. Z. Kanevskaya, S. S. Yakushin
Format: Article
Language:Russian
Published: IMA PRESS LLC 2018-07-01
Series:Научно-практическая ревматология
Subjects:
disease-modifying antirheumatic drugs
early rheumatoid arthritis
remission
interleukin 6
tocilizumab
Online Access:https://rsp.mediar-press.net/rsp/article/view/2560

Internet

https://rsp.mediar-press.net/rsp/article/view/2560

Similar Items